• 1. Applications of liquid crystals in biosensing
  Ziyihui Wang,Tianhua Xu,Adam Noel,Yu-Cheng Chen,Tiegen Liu Soft Matter 2021 17 4675
• 2. Real-time liquid crystal-based biosensor for urea detection
  Mashooq Khan,Youngkyoo Kim,Joon Hyung Lee,Inn-Kyu Kang,Soo-Young Park Anal. Methods 2014 6 5753
• 3. Configuration change of liquid crystal microdroplets coated with a novel polyacrylic acid block liquid crystalline polymer by protein adsorption
  Waliullah Khan,Soo-Young Park Lab Chip 2012 12 4553
• 4. Synthesis, linear dichroism and mesogenic properties of substituted azulenes
  Roger Brettle,David A. Dunmur,Sian Estdale,Charles M. Marson J. Mater. Chem. 1993 3 327
• 5. Extended liquid-crystalline oligofluorenes with photo- and electroluminescence
  Jesús del Barrio,Luiz Silvino Chinelatto Jr.,José Luis Serrano,Luis Oriol,Milagros Pi?ol,Henk J. Bolink New J. Chem. 2010 34 2785

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Recent Advances in the Study of Np(4-N-pentylphenyl)benzoicacid (CAS: 59662-47-4) in Chemical Biology and Pharmaceutical Research

In recent years, the compound Np(4-N-pentylphenyl)benzoicacid (CAS: 59662-47-4) has garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique structural features, has shown promising potential in various therapeutic applications. The growing body of literature on this compound highlights its role in modulating biological pathways, particularly in the context of inflammation and cancer. Researchers have been actively investigating its mechanisms of action, pharmacokinetics, and potential as a lead compound for drug development.

One of the key areas of interest is the compound's ability to interact with specific molecular targets, such as enzymes and receptors, which are critical in disease progression. Recent studies have demonstrated that Np(4-N-pentylphenyl)benzoicacid exhibits inhibitory effects on certain inflammatory mediators, making it a candidate for anti-inflammatory therapies. Additionally, its structural analogs have been explored for their potential in targeting cancer cells, with preliminary results indicating selective cytotoxicity against tumor cells while sparing normal tissues.

The synthesis and optimization of Np(4-N-pentylphenyl)benzoicacid derivatives have also been a focal point of recent research. Advances in synthetic chemistry have enabled the development of more potent and selective analogs, which are being evaluated in preclinical models. These efforts are aimed at improving the compound's bioavailability, stability, and therapeutic index. Furthermore, computational modeling and structure-activity relationship (SAR) studies have provided valuable insights into the molecular interactions that underpin its biological activity.

In terms of pharmacological applications, Np(4-N-pentylphenyl)benzoicacid has been investigated for its potential in combination therapies. Synergistic effects have been observed when this compound is used alongside conventional chemotherapeutic agents, suggesting its utility in enhancing treatment efficacy and overcoming drug resistance. These findings are particularly relevant in the context of multidrug-resistant cancers, where novel therapeutic strategies are urgently needed.

Despite these promising developments, challenges remain in translating the preclinical findings into clinical applications. Issues such as formulation stability, dose optimization, and potential off-target effects need to be addressed in future studies. Nevertheless, the ongoing research on Np(4-N-pentylphenyl)benzoicacid underscores its potential as a valuable tool in chemical biology and a promising candidate for pharmaceutical development.

In conclusion, the study of Np(4-N-pentylphenyl)benzoicacid (CAS: 59662-47-4) represents a vibrant and rapidly evolving area of research. Its multifaceted biological activities and therapeutic potential make it a compelling subject for further investigation. As researchers continue to unravel its mechanisms and optimize its properties, this compound may pave the way for novel treatments in inflammation, oncology, and beyond.

• 88038-94-2(4-(4-N-Propylphenyl)benzoic Acid)
• 59662-48-5(4-(4-Hexylphenyl)benzoic Acid)
• 920270-34-4([1,1'-Biphenyl]-4-carboxylic acid, 4'-heptyl-2-methyl-)
• 62614-48-6(4'-(2S)-2-Methylbutyl-1,1'-biphenyl-4-carboxylicacid)
• 59662-46-3(4'-Butylbiphenyl-4-carboxylic Acid)
• 920269-55-2([1,1'-Biphenyl]-4-carboxylic acid, 2-methyl-4'-octyl-)
• 58573-94-7(4-(4-Heptylphenyl)benzoic Acid)
• 59662-49-6(AC-55649)
• 129720-19-0([1,1'-Biphenyl]-4-carboxylic acid, 3'-methyl-4'-pentyl-)
• 118826-99-6([1,1'-Biphenyl]-4-carboxylic acid, 4'-nonyl-)